U.S. Senate · 119th Congress · S. 3510
Biosimilar Inspection Modernization Act of 2025
A bill to improve the inspections of drug establishments engaged in the manufacture, preparation, propagation, or processing of biosimilar biological products conducted by the Food and Drug Administration, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Ted BuddR-NC
- Introduced
- December 16, 2025, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (1)
1 Democrat. Each member is shown with the party they were counted with on the day they signed on. How we count these